Oxygenta Pharma

  • Market Cap: Micro Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: INE102E01018
  • NSEID:
  • BSEID: 524636
INR
54.10
0.00 (0.00%)
BSENSE

Dec 26

BSE+NSE Vol: 4.85 k

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
{
  "main_header": {
    "sid": 798135,
    "name": "Oxygenta Pharma",
    "stock_name": "Oxygenta Pharma",
    "full_name": "Oxygenta Pharmaceutical Ltd",
    "name_url": "stocks-analysis/oxygenta-pharma",
    "exchange": 0,
    "exchangecode": "",
    "country_id": 34,
    "currency": "INR",
    "cmp": "54.10",
    "chg": "0.00",
    "chgp": "0.00%",
    "dir": 0,
    "prev_price": "54.10",
    "mcapval": "212.00 Cr",
    "mcap": "Micro Cap",
    "scripcode": 524636,
    "symbol": "",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 4,
    "indexname": "",
    "isin": "INE102E01018",
    "curr_date": "Dec 26",
    "curr_time": "",
    "bse_nse_vol": "4.85 k",
    "exc_status": "Active",
    "traded_date": "Dec 26, 2025",
    "traded_date_str": "2025 12 26",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-registerF-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/oxygenta-pharma-798135-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0
    }
  },
  "news": {
    "results": [
      {
        "title": "Oxygenta Pharmaceutical Ltd is Rated Strong Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/oxygenta-pharmaceutical-ltd-is-rated-strong-sell-3768644",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/12/OxygentaPharmac_mojoScore_3768644.png",
        "date": "2025-12-24 20:23:06",
        "description": "Oxygenta Pharmaceutical Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 01 Sep 2025. However, the analysis and financial metrics discussed here reflect the company’s current position as of 24 December 2025, providing investors with the latest insights into its performance and outlook."
      },
      {
        "title": "Oxygenta Pharmaceutical Stock Hits 52-Week Low at Rs.52.1 Amidst Market Pressure",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/oxygenta-pharmaceutical-stock-hits-52-week-low-amidst-continued-decline-3760142",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/12/OxygentaPharmac_priceRelatedfactors_3760142.png",
        "date": "2025-12-16 12:21:16",
        "description": "Oxygenta Pharmaceutical has reached a new 52-week low of Rs.52.1, marking a significant decline in its stock price amid a broader market downturn. The stock has underperformed its sector and the benchmark indices, reflecting ongoing challenges within the company and the pharmaceuticals sector."
      },
      {
        "title": "Why is Oxygenta Pharma falling/rising?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/why-is-oxygenta-pharma-fallingrising-3759140",
        "imagepath": "",
        "date": "2025-12-16 00:48:22",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n\n<p><strong>Recent Price Movement and Market Context</strong></p>\n<p>Oxygenta Pharma’s share price has been under pressure over the past week, falling by 6.60% compared to a marginal 0.13% gain in the Sensex. The one-month performance further emphasises this trend, with the stock declining 8.58% while the Sensex rose by 0.77%. Year-to-date, the stock has suffered a steep 36.42% loss, in stark contrast to the Sensex’s 9.05% gain. Over the last year, the stock’s decline of 38.32% is again at odds with the Sensex’s positive 3.75% return. These figures highlight a persistent underperformance relative to the benchmark index.</p>\n<p>Despite this recent weakness, it is notable that over longer horizons, Oxygenta Pharma has delivered substantial gains. The three-year return stands at an impressive 119.80%, sign..."
      },
      {
        "title": "Oxygenta Pharma’s Evaluation Revised Amidst Challenging Financial and Market Conditions",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/oxygenta-pharma-downgraded-to-strong-sell-amid-deteriorating-fundamentals-3744024",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/12/OxygentaPharma_mojoScore_3744024.png",
        "date": "2025-12-03 11:08:14",
        "description": "Oxygenta Pharma has experienced a revision in its market evaluation, reflecting shifts in its financial performance and market positioning. This adjustment highlights ongoing challenges within the Pharmaceuticals & Biotechnology sector, particularly for microcap companies facing operational and valuation pressures."
      },
      {
        "title": "Oxygenta Pharmaceutical Sees Extraordinary Buying Interest Amid Upper Circuit Scenario",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/oxygenta-pharmaceutical-hits-upper-circuit-amidst-unprecedented-buying-interest-3720527",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/11/OxygentaPharmac_only_buyers_3720527.png",
        "date": "2025-11-21 10:10:38",
        "description": "Oxygenta Pharmaceutical has attracted remarkable buying interest today, with the stock hitting an upper circuit and registering only buy orders in the queue. This unusual market behaviour signals a potential multi-day circuit scenario, reflecting strong demand despite recent price pressures and sector trends."
      },
      {
        "title": "Oxygenta Pharmaceutical Ltd Surges 5% Today, Reaching Intraday High of Rs 63.87",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/oxygenta-pharmaceutical-ltd-surges-5-today-reaching-intraday-high-of-rs-6387-3706847",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/11/OxygentaPharmac_only_buyers_3706847.png",
        "date": "2025-11-17 10:20:39",
        "description": "Oxygenta Pharmaceutical Ltd is experiencing notable buying activity, with a significant stock increase today, reversing a two-day decline. Despite recent challenges, the stock has shown impressive long-term growth over five years. Current performance metrics indicate mixed technical signals, reflecting ongoing market sentiment and potential sector developments."
      },
      {
        "title": "Oxygenta Pharmaceutical Ltd Surges 4.99% Today, Reaching Intraday High of Rs 63.99",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/oxygenta-pharmaceutical-ltd-surges-499-today-reaching-intraday-high-of-rs-6399-3701019",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/11/OxygentaPharmac_only_buyers_3701019.png",
        "date": "2025-11-14 10:00:36",
        "description": "Oxygenta Pharmaceutical Ltd is experiencing notable buying activity, with the stock rising significantly today, in contrast to a decline in the Sensex. Despite recent challenges, the stock has shown resilience over the past month, outperforming the index, while current trading indicates mixed trends in the short to medium term."
      },
      {
        "title": "Why is Oxygenta Pharma falling/rising?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/why-is-oxygenta-pharma-fallingrising-3687134",
        "imagepath": "",
        "date": "2025-11-10 23:00:10",
        "description": "As of 10-Nov, Oxygenta Pharmaceutical Ltd is experiencing a decline in its stock price, currently at Rs 62.40, which reflects a decrease of Rs 2.07 or 3.21%. The stock has been underperforming, having lost 6.64% over the last two days and is currently trading below its recent moving averages, specifically lower than the 5-day, 50-day, 100-day, and 200-day moving averages. Additionally, the stock has underperformed its sector by 4.26% today. In terms of returns, over the past week, the stock has decreased by 3.81%, while it has shown a significant decline of 28.66% year-to-date and 29.76% over the past year, despite a strong performance over the last three and five years.\n\nBroader Market Context: In comparison to the benchmark Sensex, which has only decreased by 0.53% over the past week, Oxygenta's short-term performance is notably weaker. The Sensex has shown a positive return of 1.25% over the past month, ..."
      },
      {
        "title": "Oxygenta Pharmaceutical Ltd Faces Significant Selling Pressure with 35.03% Decline Over Three Months",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/oxygenta-pharmaceutical-ltd-faces-significant-selling-pressure-with-3503-decline-over-three-months-3684736",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/11/OxygentaPharmac_only_sellers_3684736.png",
        "date": "2025-11-10 09:31:43",
        "description": "Oxygenta Pharmaceutical Ltd is experiencing significant selling pressure, with consecutive losses leading to an 8.29% decline over two days. The stock has underperformed against the Sensex, showing a 35.03% drop over the past three months and trading below key moving averages, indicating ongoing challenges in the market."
      }
    ],
    "total": 208,
    "sid": "798135",
    "stock_news_url": "https://www.marketsmojo.com/news/oxygenta-pharmaceutical-798135"
  },
  "announcements": [
    {
      "caption": "Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011",
      "datetime": "17-Dec-2025",
      "details": "The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations 2011 for Virupaksha Organics Ltd",
      "source": "BSE"
    },
    {
      "caption": "Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011",
      "datetime": "17-Dec-2025",
      "details": "The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations 2011 for Virupaksha Organics Ltd",
      "source": "BSE"
    },
    {
      "caption": "Shareholder Meeting / Postal Ballot-Outcome of Postal_Ballot",
      "datetime": "11-Dec-2025",
      "details": "Outcome of the Postal Ballot",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "No <strong>Dividend</strong> history available",
      "data": []
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "No <strong>Splits</strong> history available",
      "data": []
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "No <strong>Bonus</strong> history available",
      "data": []
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}
stock newsNews and Views

Why is Oxygenta Pharma falling/rising?

2025-12-16 00:48:22

Recent Price Movement and Market Context

Oxygenta Pharma’s share price has been under pressure over the past week, falling by 6.60% compared to a marginal 0.13% gain in the Sensex. The one-month performance further emphasises this trend, with the stock declining 8.58% while the Sensex rose by 0.77%. Year-to-date, the stock has suffered a steep 36.42% loss, in stark contrast to the Sensex’s 9.05% gain. Over the last year, the stock’s decline of 38.32% is again at odds with the Sensex’s positive 3.75% return. These figures highlight a persistent underperformance relative to the benchmark index.

Despite this recent weakness, it is notable that over longer horizons, Oxygenta Pharma has delivered substantial gains. The three-year return stands at an impressive 119.80%, sign...

Read More
stock-recommendationAnnouncement

Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011

17-Dec-2025 | Source : BSE

The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations 2011 for Virupaksha Organics Ltd

Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011

17-Dec-2025 | Source : BSE

The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations 2011 for Virupaksha Organics Ltd

Shareholder Meeting / Postal Ballot-Outcome of Postal_Ballot

11-Dec-2025 | Source : BSE

Outcome of the Postal Ballot

stock-recommendationCorporate Actions
Corporate Actions
info
stock-summary
BOARD MEETING

No Upcoming Board Meetings

stock-summary
DIVIDEND

No Dividend history available

stock-summary
SPLITS

No Splits history available

stock-summary
BONUS

No Bonus history available

stock-summary
RIGHTS

No Rights history available